title: IncobotulinumtoxinA in esthetics.
abstract: IncobotulinumtoxinA (Xeomin®/Xeomeen®/Bocouture®/XEOMIN Cosmetic™) is a botulinum toxin type A that differs from other commercially available botulinum toxin type A preparations in that it is free from complexing proteins ([150 kDa]/NT 201). The proven efficacy of incobotulinumtoxinA in various therapeutic indications preceded its use in the field of esthetic medicine, where it is widely approved for the treatment of glabellar frown lines on the basis of positive efficacy and safety findings from a number of clinical trials. Here, we discuss the characteristics of incobotulinumtoxinA and review the clinical data supporting its use in esthetics.
authors.affiliation: Division of Cosmetic Sciences, Department of Chemistry, University of Hamburg, Hamburg, Germany. martina.kerscher@uni-hamburg.de
authors.forename: Martina
authors.initials: M
authors.lastname: Kerscher
authors.forename: Yana
authors.initials: Y
authors.lastname: Yutskovskaya
authors.forename: Timothy Corcoran
authors.initials: TC
authors.lastname: Flynn
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000737:chemistry; D003357:Cosmetic Techniques; D004954:Esthetics; D006801:Humans; D009465:Neuromuscular Agents / Q000008:administration & dosage* / Q000737:chemistry; D015595:Skin Aging / Q000187:drug effects
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; C545476:incobotulinumtoxinA